MedUX — Series C (estimated) · €4.1M

MedUX closed a €4.1M round co-led by existing investors BTS Group and Inveready, with a group of family offices and investors holding positions in other TMT companies also taking part; because two investors are jointly credited as leads, lead_investor is left null and both are flagged as leads in the investor list. Proceeds were earmarked for international growth (organic and inorganic), consolidating its Latin America position and scaling the QoE Everywhere product suite. No source gives it a series letter; it is treated as a follow-on at the same stage as the February 2022 round, given the identical investor group.